Home LiteratureArticle Details
PMID: 24727385 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Review

Signaling pathways involved in MDSC regulation.

Biochimica et biophysica acta ·Vol. 1846 ·No. 1 ·2014-08-00 ·Pages 55-65

Trikha P, Carson WE

Abstract

The immune system has evolved mechanisms to protect the host from the deleterious effects of inflammation. The generation of immune suppressive cells like myeloid derived suppressor cells (MDSCs) that can counteract T cell responses represents one such strategy. There is an accumulation of immature myeloid cells or MDSCs in bone marrow (BM) and lymphoid organs under pathological conditions such as cancer. MDSCs represent a population of heterogeneous myeloid cells comprising of macrophages, granulocytes and dendritic cells that are at early stages of development. Although, the precise signaling pathways and molecular mechanisms that lead to MDSC generation and expansion in cancer remains to be elucidated. It is widely believed that perturbation of signaling pathways involved during normal hematopoietic and myeloid development under pathological conditions such as tumorogenesis contributes to the development of suppressive myeloid cells. In this review we discuss the role played by key signaling pathways such as PI3K, Ras, Jak/Stat and TGFb during myeloid development and how their deregulation under pathological conditions can lead to the generation of suppressive myeloid cells or MDSCs. Targeting these pathways should help in elucidating mechanisms that lead to the expansion of MDSCs in cancer and point to methods for eliminating these cells from the tumor microenvironment.

Keywords
Jak/Stat Myeloid derived suppressor cells (MDSC) PI3K Ras TGFβ Tumor microenvironment
MeSH Terms
Animals Cell Transformation, Neoplastic/immunology Cytokines/physiology Dendritic Cells/physiology Granulocytes/physiology Humans Macrophages/physiology Myeloid Cells/physiology Neoplasms/immunology,prevention & control Signal Transduction/physiology
Chemicals
Cytokines
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Trikha Prashant
Comprehensive Cancer Center, The Ohio State University, USA. Electronic address: prashant.trikha@osumc.edu.
Carson William E
Comprehensive Cancer Center, The Ohio State University, USA; Department of Surgery, The Ohio State University, Columbus, OH 43210, USA. Electronic address: william.carson@osumc.edu.
References (156)
156 references, click to expand
  1. Fas signal promotes lung cancer growth by recruiting myeloid-derived suppressor cells via cancer cell-derived PGE2.
    J Immunol. 2009 Mar 15;182(6):3801-8 PMID: 19265159
  2. Immature immunosuppressive CD14+HLA-DR-/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign.
    Cancer Res. 2010 Jun 1;70(11):4335-45 PMID: 20484028
  3. Tryptophan 650 of human granulocyte colony-stimulating factor (G-CSF) receptor, implicated in the activation of JAK2, is also required for G-CSF-mediated activation of signaling complexes of the p21ras route.
    Blood. 1996 Mar 15;87(6):2148-53 PMID: 8630373
  4. A CSF-1 receptor kinase inhibitor targets effector functions and inhibits pro-inflammatory cytokine production from murine macrophage populations.
    FASEB J. 2006 Sep;20(11):1921-3 PMID: 16877523
  5. Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression.
    Cancer Cell. 2011 Apr 12;19(4):441-55 PMID: 21481787
  6. Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients.
    J Immunol. 2004 Jun 15;172(12):7335-40 PMID: 15187109
  7. Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progression.
    Eur J Cancer. 2004 Jul;40(11):1660-7 PMID: 15251154
  8. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.
    Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3539-43 PMID: 8097319
  9. Prevalence of ras gene mutations in human colorectal cancers.
    Nature. 1987 May 28-Jun 3;327(6120):293-7 PMID: 3587348
  10. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.
    J Exp Med. 2005 Oct 17;202(8):1075-85 PMID: 16230475
  11. Myeloid-derived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties.
    J Leukoc Biol. 2011 Feb;89(2):311-7 PMID: 21106641
  12. Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia.
    N Engl J Med. 1995 Aug 24;333(8):487-93 PMID: 7542747
  13. Myeloid lineage commitment from the hematopoietic stem cell.
    Immunity. 2007 Jun;26(6):726-40 PMID: 17582345
  14. Reversal of myeloid cell-mediated immunosuppression in patients with metastatic renal cell carcinoma.
    Clin Cancer Res. 2008 Dec 15;14(24):8270-8 PMID: 19088044
  15. Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host.
    Cancer Res. 2006 Jan 15;66(2):1123-31 PMID: 16424049
  16. Development and function of myeloid-derived suppressor cells generated from mouse embryonic and hematopoietic stem cells.
    Stem Cells. 2010 Mar 31;28(3):620-32 PMID: 20073041
  17. Induction of monocytic differentiation and tumorigenicity by v-Ha-ras in differentiation arrested hematopoietic cells.
    Blood. 1993 Apr 1;81(7):1841-8 PMID: 8461470
  18. Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells.
    Cancer Res. 2007 May 1;67(9):4507-13 PMID: 17483367
  19. Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival.
    Nat Med. 2012 Aug;18(8):1254-61 PMID: 22842478
  20. Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression.
    Cancer Res. 2007 Oct 15;67(20):10019-26 PMID: 17942936
  21. Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function.
    J Exp Med. 2006 Nov 27;203(12):2691-702 PMID: 17101732
  22. Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span.
    Genes Dev. 1998 Jun 1;12(11):1610-20 PMID: 9620849
  23. Prostaglandin E2 at new glance: novel insights in functional diversity offer therapeutic chances.
    Int J Biochem Cell Biol. 2010 Feb;42(2):198-201 PMID: 19788928
  24. Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer.
    Prostate. 2010 Mar 1;70(4):443-55 PMID: 19902470
  25. Hallmarks of cancer: the next generation.
    Cell. 2011 Mar 4;144(5):646-74 PMID: 21376230
  26. Lung cancer patients' CD4(+) T cells are activated in vitro by MHC II cell-based vaccines despite the presence of myeloid-derived suppressor cells.
    Cancer Immunol Immunother. 2008 Oct;57(10):1493-504 PMID: 18322683
  27. Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells.
    J Immunol. 2008 Oct 1;181(7):4666-75 PMID: 18802069
  28. Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells.
    J Clin Invest. 2010 Feb;120(2):457-71 PMID: 20093776
  29. Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice.
    Cancer Cell. 2008 Nov 4;14(5):408-19 PMID: 18977329
  30. Cell-fate conversion of lymphoid-committed progenitors by instructive actions of cytokines.
    Nature. 2000 Sep 21;407(6802):383-6 PMID: 11014194
  31. Distinct myeloid suppressor cell subsets correlate with plasma IL-6 and IL-10 and reduced interferon-alpha signaling in CD4⁺ T cells from patients with GI malignancy.
    Cancer Immunol Immunother. 2011 Sep;60(9):1269-79 PMID: 21604071
  32. TGF-beta: a mobile purveyor of immune privilege.
    Immunol Rev. 2006 Oct;213:213-27 PMID: 16972906
  33. The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants.
    Science. 1997 Jul 18;277(5324):333-8 PMID: 9219684
  34. Cutting edge: spontaneous rejection of poorly immunogenic P1.HTR tumors by Stat6-deficient mice.
    J Immunol. 2000 Dec 1;165(11):6024-8 PMID: 11086033
  35. Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis.
    Cancer Cell. 2008 Jan;13(1):23-35 PMID: 18167337
  36. E2f1-3 are critical for myeloid development.
    J Biol Chem. 2011 Feb 11;286(6):4783-95 PMID: 21115501
  37. Granulocyte-macrophage colony-stimulating factor regulates effector differentiation of invariant natural killer T cells during thymic ontogeny.
    Immunity. 2006 Sep;25(3):487-97 PMID: 16949316
  38. Activation of phosphoinositide 3-kinase gamma by Ras.
    Curr Biol. 2002 Jul 9;12(13):1068-75 PMID: 12121613
  39. Expression of granulocyte-colony stimulating factor and its receptor is regulated during the development of the human placenta.
    J Endocrinol. 1996 May;149(2):249-58 PMID: 8708536
  40. Tumor-derived G-CSF facilitates neoplastic growth through a granulocytic myeloid-derived suppressor cell-dependent mechanism.
    PLoS One. 2011;6(11):e27690 PMID: 22110722
  41. Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples.
    J Immunol Methods. 2012 Jul 31;381(1-2):14-22 PMID: 22522114
  42. Subsets of myeloid-derived suppressor cells in tumor-bearing mice.
    J Immunol. 2008 Oct 15;181(8):5791-802 PMID: 18832739
  43. Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein.
    J Exp Med. 2008 Sep 29;205(10):2235-49 PMID: 18809714
  44. IL4Ralpha+ myeloid-derived suppressor cell expansion in cancer patients.
    J Immunol. 2009 May 15;182(10):6562-8 PMID: 19414811
  45. Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells.
    J Immunol. 2010 Aug 15;185(4):2273-84 PMID: 20644162
  46. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation.
    J Exp Med. 1992 Jul 1;176(1):287-92 PMID: 1613462
  47. Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients.
    Cancer Res. 2001 Jun 15;61(12):4756-60 PMID: 11406548
  48. Myeloid-derived suppressor cells as regulators of the immune system.
    Nat Rev Immunol. 2009 Mar;9(3):162-74 PMID: 19197294
  49. SOCS3 negatively regulates IL-6 signaling in vivo.
    Nat Immunol. 2003 Jun;4(6):540-5 PMID: 12754505
  50. PGE(2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment.
    Cancer Res. 2011 Dec 15;71(24):7463-70 PMID: 22025564
  51. Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580.
    Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):16078-83 PMID: 16249345
  52. STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients.
    J Clin Invest. 2013 Apr;123(4):1580-9 PMID: 23454751
  53. Aberrant activation of JAK/STAT pathway components in response to G-CSF, interferon-alpha/beta and interferon-gamma in NFS-60 cells.
    Growth Factors. 1996;13(3-4):251-60 PMID: 8919032
  54. Expression cloning of a human granulocyte colony-stimulating factor receptor: a structural mosaic of hematopoietin receptor, immunoglobulin, and fibronectin domains.
    J Exp Med. 1990 Dec 1;172(6):1559-70 PMID: 2147944
  55. Phosphatidylinositol 3-kinase c2alpha contains a nuclear localization sequence and associates with nuclear speckles.
    J Biol Chem. 2001 Dec 21;276(51):48135-42 PMID: 11606566
  56. Ras signaling enhances the activity of C/EBP alpha to induce granulocytic differentiation by phosphorylation of serine 248.
    J Biol Chem. 2002 Jul 19;277(29):26293-9 PMID: 11978795
  57. Sunitinib reverses type-1 immune suppression and decreases T-regulatory cells in renal cell carcinoma patients.
    Clin Cancer Res. 2008 Oct 15;14(20):6674-82 PMID: 18927310
  58. G-CSF is an essential regulator of neutrophil trafficking from the bone marrow to the blood.
    Immunity. 2002 Oct;17(4):413-23 PMID: 12387736
  59. Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer.
    Nat Immunol. 2013 Mar;14(3):211-20 PMID: 23354483
  60. Incomplete restoration of colony-stimulating factor 1 (CSF-1) function in CSF-1-deficient Csf1op/Csf1op mice by transgenic expression of cell surface CSF-1.
    Blood. 2004 Feb 1;103(3):1114-23 PMID: 14525772
  61. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis.
    Cell. 2006 Jan 27;124(2):263-6 PMID: 16439202
  62. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages.
    Nature. 2000 Mar 9;404(6774):193-7 PMID: 10724173
  63. E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells.
    Nature. 2009 Dec 17;462(7275):930-4 PMID: 20016602
  64. G-CSF stem cell mobilization in human donors induces polymorphonuclear and mononuclear myeloid-derived suppressor cells.
    Clin Immunol. 2012 Apr;143(1):83-7 PMID: 22341087
  65. Colony-stimulating factor 1-induced STAT1 and STAT3 activation is accompanied by phosphorylation of Tyk2 in macrophages and Tyk2 and JAK1 in fibroblasts.
    Blood. 1995 Oct 15;86(8):2948-56 PMID: 7579387
  66. Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblasts.
    Eur J Immunol. 1998 Jan;28(1):122-33 PMID: 9485192
  67. The JAK-STAT pathway at twenty.
    Immunity. 2012 Apr 20;36(4):503-14 PMID: 22520844
  68. Phase I study of continuous-infusion recombinant macrophage colony-stimulating factor in patients with metastatic melanoma.
    Clin Cancer Res. 1996 Feb;2(2):295-302 PMID: 9816172
  69. Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma.
    Neuro Oncol. 2011 Jun;13(6):591-9 PMID: 21636707
  70. Colony stimulating factors and myeloid cell biology in health and disease.
    Trends Immunol. 2013 Feb;34(2):81-9 PMID: 23000011
  71. Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients.
    Clin Cancer Res. 2009 Mar 15;15(6):2148-57 PMID: 19276286
  72. A specific p47phox -serine phosphorylated by convergent MAPKs mediates neutrophil NADPH oxidase priming at inflammatory sites.
    J Clin Invest. 2006 Jul;116(7):2033-43 PMID: 16778989
  73. Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy.
    Cancer Immunol Immunother. 2009 Jan;58(1):49-59 PMID: 18446337
  74. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression.
    J Immunol. 2006 Nov 15;177(10):7303-11 PMID: 17082649
  75. IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice.
    J Immunol. 2003 Jan 1;170(1):270-8 PMID: 12496409
  76. Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis.
    Nat Rev Cancer. 2006 Mar;6(3):184-92 PMID: 16453012
  77. Rb regulates interactions between hematopoietic stem cells and their bone marrow microenvironment.
    Cell. 2007 Jun 15;129(6):1081-95 PMID: 17574022
  78. Regulation of systemic and local myeloid cell subpopulations by bone marrow cell-derived granulocyte-macrophage colony-stimulating factor in experimental inflammatory arthritis.
    Arthritis Rheum. 2011 Aug;63(8):2340-51 PMID: 21809323
  79. Differential regulation of protrusion and polarity by PI3K during neutrophil motility in live zebrafish.
    Dev Cell. 2010 Feb 16;18(2):226-36 PMID: 20159593
  80. Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine.
    J Clin Oncol. 2007 Jun 20;25(18):2546-53 PMID: 17577033
  81. Population alterations of L-arginase- and inducible nitric oxide synthase-expressed CD11b+/CD14⁻/CD15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer.
    J Cancer Res Clin Oncol. 2010 Jan;136(1):35-45 PMID: 19572148
  82. The TSC-mTOR signaling pathway regulates the innate inflammatory response.
    Immunity. 2008 Oct 17;29(4):565-77 PMID: 18848473
  83. Myeloid-derived suppressor cell inhibition of the IFN response in tumor-bearing mice.
    Cancer Res. 2011 Aug 1;71(15):5101-10 PMID: 21680779
  84. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes.
    Trends Immunol. 2002 Nov;23(11):549-55 PMID: 12401408
  85. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.
    Science. 1994 Jun 3;264(5164):1415-21 PMID: 8197455
  86. Macrophage-induced tumor angiogenesis is regulated by the TSC2-mTOR pathway.
    Cancer Res. 2012 Mar 15;72(6):1363-72 PMID: 22287548
  87. Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease.
    J Immunol. 2005 Jan 15;174(2):636-45 PMID: 15634881
  88. Macrophage activation and polarization.
    Front Biosci. 2008 Jan 01;13:453-61 PMID: 17981560
  89. Transgenic expression of CSF-1 in CSF-1 receptor-expressing cells leads to macrophage activation, osteoporosis, and early death.
    J Leukoc Biol. 2006 Dec;80(6):1445-53 PMID: 16973889
  90. STAT3 controls myeloid progenitor growth during emergency granulopoiesis.
    Blood. 2010 Oct 7;116(14):2462-71 PMID: 20581311
  91. Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells.
    J Immunol. 2009 May 1;182(9):5693-701 PMID: 19380816
  92. Tyrosine kinase JAK1 is associated with the granulocyte-colony-stimulating factor receptor and both become tyrosine-phosphorylated after receptor activation.
    Proc Natl Acad Sci U S A. 1994 Apr 12;91(8):2985-8 PMID: 7512720
  93. Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis.
    Cancer Res. 1995 Oct 15;55(20):4575-80 PMID: 7553632
  94. SHIP's C-terminus is essential for its hydrolysis of PIP3 and inhibition of mast cell degranulation.
    Blood. 2001 Mar 1;97(5):1343-51 PMID: 11222379
  95. New roles of Rb1 in expansion of MDSCs in cancer.
    Cell Cycle. 2013 May 1;12(9):1329-30 PMID: 23588070
  96. Multiple levels of MHC class I down-regulation by ras oncogenes.
    Scand J Immunol. 1996 May;43(5):537-44 PMID: 8633212
  97. Involvement of phosphatidylinositol 3-kinase gamma in neutrophil apoptosis.
    Cell Signal. 2003 Feb;15(2):225-33 PMID: 12464394
  98. All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients.
    Cancer Res. 2006 Sep 15;66(18):9299-307 PMID: 16982775
  99. The unholy trinity: inflammation, cytokines, and STAT3 shape the cancer microenvironment.
    Cancer Cell. 2011 Apr 12;19(4):429-31 PMID: 21481782
  100. Pancreatic cancer-associated stellate cells: A viable target for reducing immunosuppression in the tumor microenvironment.
    Oncoimmunology. 2013 Jul 1;2(7):e24891 PMID: 24073373
  101. Signal transducer and activator of transcription 3 (Stat3C) promotes myeloid-derived suppressor cell expansion and immune suppression during lung tumorigenesis.
    Am J Pathol. 2011 Oct;179(4):2131-41 PMID: 21864492
  102. Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression.
    Nat Med. 2011 Mar;17(3):320-9 PMID: 21383745
  103. IL-1β regulates a novel myeloid-derived suppressor cell subset that impairs NK cell development and function.
    Eur J Immunol. 2010 Dec;40(12):3347-57 PMID: 21110318
  104. Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axis.
    J Clin Invest. 2013 Oct;123(10):4464-78 PMID: 24091328
  105. GM-CSF in inflammation and autoimmunity.
    Trends Immunol. 2002 Aug;23(8):403-8 PMID: 12133803
  106. Sunitinib inhibition of Stat3 induces renal cell carcinoma tumor cell apoptosis and reduces immunosuppressive cells.
    Cancer Res. 2009 Mar 15;69(6):2506-13 PMID: 19244102
  107. Granulocyte colony-stimulating factor and its receptor.
    Blood. 1991 Dec 1;78(11):2791-808 PMID: 1720034
  108. Extramedullary hematopoiesis generates Ly-6C(high) monocytes that infiltrate atherosclerotic lesions.
    Circulation. 2012 Jan 17;125(2):364-74 PMID: 22144566
  109. Suppression of T cell proliferation by tumor-induced granulocyte-macrophage progenitor cells producing transforming growth factor-beta and nitric oxide.
    J Immunol. 1996 Mar 1;156(5):1916-22 PMID: 8596044
  110. Rapamycin and mTOR kinase inhibitors.
    J Chem Biol. 2008 Nov;1(1-4):27-36 PMID: 19568796
  111. Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence.
    J Exp Med. 2003 Dec 1;198(11):1741-52 PMID: 14657224
  112. [Myeloid-derived suppressor cells: a key player in cancer].
    Med Sci (Paris). 2010 Jun-Jul;26(6-7):576-9 PMID: 20619155
  113. Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion.
    Cancer Res. 2005 Apr 15;65(8):3044-8 PMID: 15833831
  114. Mirimostim (macrophage colony-stimulating factor; M-CSF) improves chemotherapy-induced impaired natural killer cell activity, Th1/Th2 balance, and granulocyte function.
    Cancer Sci. 2003 Sep;94(9):814-20 PMID: 12967481
  115. Mechanisms of immune suppression in patients with head and neck cancer: presence of CD34(+) cells which suppress immune functions within cancers that secrete granulocyte-macrophage colony-stimulating factor.
    Clin Cancer Res. 1995 Jan;1(1):95-103 PMID: 9815891
  116. S100A9 a new marker for monocytic human myeloid-derived suppressor cells.
    Immunology. 2012 Jun;136(2):176-83 PMID: 22304731
  117. A novel strategy for modulation of MDSC to enhance cancer immunotherapy.
    Oncoimmunology. 2012 Sep 1;1(6):984-985 PMID: 23162780
  118. SHIP represses the generation of alternatively activated macrophages.
    Immunity. 2005 Oct;23(4):361-74 PMID: 16226502
  119. MicroRNA-494 is required for the accumulation and functions of tumor-expanded myeloid-derived suppressor cells via targeting of PTEN.
    J Immunol. 2012 Jun 1;188(11):5500-10 PMID: 22544933
  120. Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes.
    Cancer Res. 2009 Feb 15;69(4):1553-60 PMID: 19201693
  121. The structure of the GM-CSF receptor complex reveals a distinct mode of cytokine receptor activation.
    Cell. 2008 Aug 8;134(3):496-507 PMID: 18692472
  122. Regression of a mammary adenocarcinoma in STAT6-/- mice is dependent on the presence of STAT6-reactive T cells.
    J Immunol. 2003 Feb 15;170(4):2014-21 PMID: 12574371
  123. hVps34 is a nutrient-regulated lipid kinase required for activation of p70 S6 kinase.
    J Biol Chem. 2005 Sep 23;280(38):33076-82 PMID: 16049009
  124. High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells.
    Cancer Res. 2004 Sep 1;64(17):6337-43 PMID: 15342423
  125. A Study of Zoledronic Acid as Neo-Adjuvant, Perioperative Therapy in Patients with Resectable Pancreatic Ductal Adenocarcinoma.
    J Cancer Ther. 2013 May;4(3):797-803 PMID: 24089656
  126. Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice.
    Science. 2002 Aug 9;297(5583):1031-4 PMID: 12130661
  127. The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1.
    Cell. 1985 Jul;41(3):665-76 PMID: 2408759
  128. Dynamics of the immune reaction to pancreatic cancer from inception to invasion.
    Cancer Res. 2007 Oct 1;67(19):9518-27 PMID: 17909062
  129. Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma.
    J Exp Med. 2005 Oct 3;202(7):931-9 PMID: 16186186
  130. Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer.
    J Immunol. 2001 Jan 1;166(1):678-89 PMID: 11123353
  131. CSF-1--a mononuclear phagocyte lineage-specific hemopoietic growth factor.
    J Cell Biochem. 1983;21(2):151-9 PMID: 6309875
  132. Regulation of granulocyte apoptosis by phosphatidylinositol 3-kinase.
    Biochem Soc Trans. 2004 Jun;32(Pt3):480-4 PMID: 15157166
  133. Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer.
    Cancer Cell. 2011 Apr 12;19(4):456-69 PMID: 21481788
  134. Targeting distinct tumor-infiltrating myeloid cells by inhibiting CSF-1 receptor: combating tumor evasion of antiangiogenic therapy.
    Blood. 2010 Feb 18;115(7):1461-71 PMID: 20008303
  135. Myeloid-derived suppressor cells from tumor-bearing mice impair TGF-β-induced differentiation of CD4+CD25+FoxP3+ Tregs from CD4+CD25-FoxP3- T cells.
    J Leukoc Biol. 2012 Nov;92(5):987-97 PMID: 22891289
  136. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm.
    Nat Immunol. 2010 Oct;11(10):889-96 PMID: 20856220
  137. Distinct signatures of the immune responses in low risk versus high risk neuroblastoma.
    J Transl Med. 2011 Oct 06;9:170 PMID: 21978632
  138. A role for immature myeloid cells in immune senescence.
    J Immunol. 2011 Jan 15;186(2):697-707 PMID: 21148798
  139. Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation.
    Science. 2000 Feb 11;287(5455):1049-53 PMID: 10669418
  140. ras genes.
    Annu Rev Biochem. 1987;56:779-827 PMID: 3304147
  141. Sunitinib-induced myeloid lineage redistribution in renal cell cancer patients: CD1c+ dendritic cell frequency predicts progression-free survival.
    Clin Cancer Res. 2008 Sep 15;14(18):5884-92 PMID: 18794101
  142. Monocyte and macrophage heterogeneity.
    Nat Rev Immunol. 2005 Dec;5(12):953-64 PMID: 16322748
  143. Hematopoietic stem cell quiescence is maintained by compound contributions of the retinoblastoma gene family.
    Cell Stem Cell. 2008 Oct 9;3(4):416-28 PMID: 18940733
  144. Pivotal Advance: Tumor-mediated induction of myeloid-derived suppressor cells and M2-polarized macrophages by altering intracellular PGE₂ catabolism in myeloid cells.
    J Leukoc Biol. 2010 Nov;88(5):839-48 PMID: 20587738
  145. Induction of myeloid-derived suppressor cells by tumor exosomes.
    Int J Cancer. 2009 Jun 1;124(11):2621-33 PMID: 19235923
  146. Delayed hematopoietic development in osteopetrotic (op/op) mice.
    J Exp Med. 1993 Jan 1;177(1):237-42 PMID: 8418205
  147. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes.
    Nat Med. 2005 Mar;11(3):305-11 PMID: 15723072
  148. A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells.
    Gastroenterology. 2008 Jul;135(1):234-43 PMID: 18485901
  149. Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice.
    J Clin Invest. 2008 Oct;118(10):3367-77 PMID: 18776941
  150. Deactivation of macrophages by transforming growth factor-beta.
    Nature. 1988 Jul 21;334(6179):260-2 PMID: 3041283
  151. The influence of granulocyte/macrophage colony-stimulating factor on dendritic cell levels in mouse lymphoid organs.
    Eur J Immunol. 1997 Jan;27(1):40-4 PMID: 9021996
  152. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism.
    Nat Rev Genet. 2006 Aug;7(8):606-19 PMID: 16847462
  153. Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1.
    J Immunol. 2009 Jan 1;182(1):240-9 PMID: 19109155
  154. Alterations in cytokine production following intraocular injection of soluble protein antigen: impairment in IFN-gamma and induction of TGF-beta and IL-4 production.
    J Immunol. 1998 Nov 15;161(10):5382-90 PMID: 9820512
  155. Suppressors of cytokine signalling (SOCS) in the immune system.
    Nat Rev Immunol. 2002 Jun;2(6):410-6 PMID: 12093007
  156. Endogenous T cell responses to antigens expressed in lung adenocarcinomas delay malignant tumor progression.
    Cancer Cell. 2011 Jan 18;19(1):72-85 PMID: 21251614
Article Info
Journal
Biochimica et biophysica acta
Abbr.
Biochim Biophys Acta
ISSN
0006-3002
Published
2014-08-00
Epub
2014-00-13
Pages
55-65
Language
English
Region
Netherlands
NLM ID
0217513
PMCID
PMC4140957
Subset
IM
Grants
NCI NIH HHS · P01 CA095426 · United States
NCI NIH HHS · P01CA095426 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com